Phase II Efficacy Study of AZD6244 in Colorectal Cancer

NCT00514761 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: AZD6244
DRUG: Capecitabine

Sponsor

AstraZeneca